Emery Brown discusses how general anesthesia can be used to understand and develop new treatments for neurological conditions, and looks ahead at the future of the field.
In this edition of NCTalks, we speak to Robyn Klein as part of our Spotlight on neuroimmunology – Robyn discusses her research, how inflammatory processes contribute to neurologic disease, and whether immunology and inflammation could be the basis of an eventual preventative treatment for neurodegenerative disease.
Lauren Pulling speaks to Bart De Strooper about his role as the Director of the new UK Dementia Research Institute and his vision for this exciting new venture.
In this interview, Patricia Garcez discusses her work on Zika virus and its disruption of normal cell division and differentiation, and her hopes for the field in the coming months and years.
Is bone marrow transplantation a viable treatment option for relapsing–remitting MS? Jeffrey Cohen discusses pros and cons of the technique.
In this interview, Mark Frasier discusses a recent Editorial from the Michael J. Fox Foundation and looks ahead to the future of precision medicine for Parkinson’s disease.
We spoke to Erica McGrath, University of Texas Medical Branch in Galveston (TX, USA), who presented her work on susceptibility to Zika virus at SfN 2016.
In this podcast we discuss the current outlook on ADHD and its diagnosis and treatment, as well as debates in the field and how the condition continues to shift in perception and treatment.
Reid Alisch discusses the role of epigenetics in neuropsychiatric disorders, and how new epigenetic research could change future research and treatment practices.
In this NCtalks podcast, we speak to Michael Merzenich, a leading professor in neuroplasticity at the University of California, San Francisco (USA), whose team was recently involved in a longitudinal trial into the effect of brain training on cognitive decline and dementia.